Skip to main content
OpenTrials
Completed

NCT Number: NCT01334164

Recovery Management Checkups for Women Offenders

The proposed study is designed to test the effectiveness of recovery management checkups for women offenders (RMC-WO) released from jail to provide continuity of care immediately upon release and to help them manage their long-term recovery. The hypotheses in the first phase were: 1)women assigned to RMC (versus control) will a) return to treatment sooner after the initial release from jail and b) be more likely to receive treatment in the 90 days after release from jail; 2)women who received treatment in the first 90 days post release (vs. no treatment) will be more likely to sustain their abstinence through 90 days post release from a) any alcohol or drugs, b) alcohol, c) cannabis, d) cocaine, and e) opiates; 3)women who maintained their abstinence from any alcohol and other drugs through the first 90 days post release (vs. any relapse) will be less likely to have a) unprotected sex, b) commit any other illegal activity, and d) be re-incarcerated in jail or prison. In the second phase repeated exposure to these efforts on a quarterly basis is expected to further strengthen each of these effects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Recovery Management Checkup (RMC) Behavior Chemically-Induced Disorders Criminal Behavior Mental Disorders Outcome Monitoring Recidivism Substance-Related Disorders

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Chestnut Health Systems-Lighthouse Institute, Chicago, Illinois, United States

Loading trial locations.

About this study

The components of the recovery management checkups will include: on-going monitoring via a re-entry meeting, two monthly meetings and quarterly assessments for 3 years, personalized feedback on substance use and high risk behaviors, linkage to community-based substance abuse treatment (when needed), on-site HIV booster sessions (when needed), and treatment engagement and retention support. Motivational interviewing will provide the therapeutic approach to transition women from one step of the change process to another. Combined, these components and therapeutic milieu afford an opportunity for immediate linkage to community-based treatment and HIV prevention as well as ongoing monitoring for relapse and early re-intervention for both substance use and HIV risk behaviors (both public health priorities).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Phase 1

Inclusion criteria

  • adult women offenders with substance problems re-entering the community from county jail programs

Exclusion criteria

  • had not used substances in the 90 days before incarceration
  • had no abuse/dependence symptoms
  • were under 18 years old
  • lived or planned to move outside Chicago within the next 12 months
  • were not fluent in English or Spanish
  • were cognitively unable to provide informed consent and were released before the 14th day of incarceration Phase 2

Inclusion criteria

  • released to the community
  • agreed to participate in the study
  • completed the initial interview

Treatment and study plan

Recovery Management Checkups

Behavioral

Women assigned to the RMC condition met with a linkage manager after each research interview. When a woman reported substance use, HIV risk behavior or illegal activity, the linkage manager used motivational interviewing to: provide feedback regarding her current substance use, HIV risk behavior or illegal activity, discuss barriers that prevented her from stopping each activity and ways of avoiding them in the future, and assess and discuss her level of motivation for change. Linkage managers also scheduled treatment appointments, accompanied the women to treatment intake and stayed through the process and implemented an Engagement and Retention Protocol designed to improve retention rates. For women who refused the treatment option, the linkage manager and participant agreed upon an Alternative Action plan, which included various behaviors the woman had agreed to engage in to reduce or stop her substance use, HIV risk, or her participation in illegal activity.

Outcome Monitoring

Other

Outcome monitoring only, however participates are still able (and do) enter treatment on their own

Primary outcomes

  1. Time to treatment re-entry

    Time frame: 3 years post release

    Time from first relapse (after release from jail) to first treatment re-entry measured in days and censored at the last observation.

  2. Any Treatment

    Time frame: Quarterly and over 3 years

    Receipt of any substance abuse treatment during each quarter and overall all observed quarters.

Secondary outcomes

  1. Abstinence

    Time frame: Quarterly and over 3 years

    Based on no self reported use and clean urine tests at 30, 60 and 90 days post release for: a) any alcohol or drugs, b) alcohol, c) cannabis, d) cocaine, and e) opiates

  2. HIV risk behaviors and Recidivism

    Time frame: Quarterly and over 3 years

    Based on no self report post release of a) unprotected sex defined as having vaginal, anal or oral sex without a barrier like a male condom, women's condom, or dental dam.; b) no self reported illegal activity other than drug use and no arrest; and c) no days in jail or prison.

Sponsors and collaborators

Lead sponsor

Chestnut Health Systems

Other

Collaborators

  • Cook County Sheriff's Women's Justice Services
  • Haymarket Center

Registry information

Official study title

Recovery Management Checkups for Women Offenders Experiment

Acronym: RMC-WO

Important dates

Study start
2007
Primary completion
2015
Study completion
2015
First posted
Apr 13, 2011
Registry last updated
Jul 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.